Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quest PharmaTechQPTFF 3-Year Share Buyback Ratio is 0.00 as of Jan. 2026. Among 1,184 Biotechnology companies, Quest PharmaTech ranks worse than 84459.38% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Quest PharmaTech's current 3-Year Share Buyback Ratio was 0.00%.
The historical rank and industry rank for Quest PharmaTech's 3-Year Share Buyback Ratio or its related term are showing as below:
During the past 13 years, Quest PharmaTech's highest 3-Year Share Buyback Ratio was 15.40%. The lowest was -26.40%. And the median was -6.25%.
QPTFF's 3-Year Share Buyback Ratio is not ranked *
in the Biotechnology industry.
Industry Median: -11.6 * Ranked among companies with meaningful 3-Year Share Buyback Ratio only.
Quest PharmaTech (OTCPK:QPTFF) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Quest PharmaTech 3-Year Share Buyback Ratio Related Terms
QPTFF vs VRTX, REGN, MRNA: 3-Year Share Buyback Ratio Comparison
For the Biotechnology subindustry, Quest PharmaTech's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest PharmaTech 3-Year Share Buyback Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Quest PharmaTech's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Quest PharmaTech's 3-Year Share Buyback Ratio falls into.
Quest PharmaTech 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.00 mean?
Quest PharmaTech (QPTFF) has a 3-Year Share Buyback Ratio of 0.00 as of Jan. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Quest PharmaTech and its competitors. According to the industry distribution chart, Quest PharmaTech ranks #999999 out of 1184 companies in the Biotechnology industry.
Is Quest PharmaTech's 3-Year Share Buyback Ratio too high?
Quest PharmaTech's current 3-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Quest PharmaTech ranks #999999 out of 1184 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Quest PharmaTech's 3-Year Share Buyback Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Quest PharmaTech ranks #999999 out of 1184 companies for 3-Year Share Buyback Ratio. This places Quest PharmaTech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Biotechnology company?
A good 3-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Quest PharmaTech and its competitors. Quest PharmaTech's current 3-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest PharmaTech stock overvalued right now?
Quest PharmaTech (QPTFF) has a current 3-Year Share Buyback Ratio of 0.00. The current 3-Year Share Buyback Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Quest PharmaTech (QPTFF), the current 3-Year Share Buyback Ratio is 0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest PharmaTech Inc. is a Canadian biopharmaceutical company focused on the development of targeted cancer therapies. Its lead program centers on the monoclonal antibody AR9.6, which targets truncated O-glycans on the MUC16 protein, a novel cancer-associated epitope discovered at the University of Nebraska Medical Center. The company is advancing this antibody as a potential treatment for cancers that overexpress MUC16, including ovarian and pancreatic cancers. Quest PharmaTech operates as a research and development-stage enterprise, generating no significant product revenue and relying on financing, partnerships, and licensing arrangements to fund its preclinical and clinical activities. Its operations are based in Canada, with research collaborations extending to academic institutions in the United States. The company's business model depends on successfully developing its antibody candidates through clinical trials and ultimately out-licensing or partnering them with larger pharmaceutical companies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QPTFF has been successfully added to your 
